Position in IDXX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,042,877
-$530,976 QoQ
Shares Held
1,981
-29.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#625
of 1,286 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. IDXX ranks #6 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
11,336 | $3,077,157 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,702 | $2,357,394 | |
| 3 | GH |
Guardant Health, Inc.
|
11,811 | $1,772,004 | |
| 4 | BDSX |
Biodesix Inc
|
46,989 | $1,059,601 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,971 | $1,053,603 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
This page
|
1,981 | $1,042,877 | |
| 7 | XGN |
Exagen Inc.
|
214,721 | $998,452 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
619 | $790,778 |
All Filings in IDXX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,042,877 | 1,981 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,573,853 | 2,801 | Shares | Sole | 2026-05-08 | |
| 2024-12-31 | $296,436 | 717 | Shares | Sole | 2025-02-07 | |
| 2024-03-31 | $1,472,389 | 2,727 | Shares | Sole | 2024-05-03 | |
| 2023-06-30 | $2,934,529 | 5,843 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $321,880 | 789 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $269,009 | 767 | Shares | Sole | 2022-08-09 | |
| 2021-09-30 | $292,914 | 471 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $361,110 | 738 | Shares | Sole | 2021-05-10 | |
| 2020-09-30 | $509,077 | 1,295 | Shares | Sole | 2020-11-06 | |
| No filing history on record for this holder in this stock. | ||||||